ThinkStock Photos has buy call on with a target price of Rs 488. The current market price of Solara Active Pharma Sciences is Rs 379.9. Time period given by analyst is one year when . price can reach defined target.
Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1364.98 Crore) operating in Pharmaceuticals sector.
Solara Active Pharma Sciences Ltd. key Products/Revenue Segments include Active Pharma Ingredients, Other Operating Revenue and Sale of services for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 337.05 Crore, down -8.13 % from last quarter Total Income of Rs 366.89 Crore and down -18.09 % from last year same quarter Total Income of Rs 411.48 Crore. Company reported net profit after tax of Rs -16.45 Crore in latest quarter.
Investment Rationale
While the brokerage believes near-term performance would remain under pressure due to business volatility, cost inflation and decline in demand, sharp correction in stock (~60% in last 6 months) have already priced in most concerns and provide comfort on valuations. Upgrade to BUY from Add with a revised target price of Rs488/share (earlier: Rs721/share).
Promoter/FII Holdings
Promoters held 40.4 per cent stake in the company as of 30-Jun-2022, while FIIs owned 17.93 per cent, DIIs 3.09 per cent.
Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1364.98 Crore) operating in Pharmaceuticals sector.
Solara Active Pharma Sciences Ltd. key Products/Revenue Segments include Active Pharma Ingredients, Other Operating Revenue and Sale of services for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 337.05 Crore, down -8.13 % from last quarter Total Income of Rs 366.89 Crore and down -18.09 % from last year same quarter Total Income of Rs 411.48 Crore. Company reported net profit after tax of Rs -16.45 Crore in latest quarter.
Investment Rationale
While the brokerage believes near-term performance would remain under pressure due to business volatility, cost inflation and decline in demand, sharp correction in stock (~60% in last 6 months) have already priced in most concerns and provide comfort on valuations. Upgrade to BUY from Add with a revised target price of Rs488/share (earlier: Rs721/share).
Promoter/FII Holdings
Promoters held 40.4 per cent stake in the company as of 30-Jun-2022, while FIIs owned 17.93 per cent, DIIs 3.09 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Experience Your Economic Times Newspaper, The Digital Way!
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by